Tauriga Sciences, Inc. announced that it has formally submitted its Clinical Study Protocol to the Institutional Review Board. The Company’s Protocol Title: The Effect of CBD Gum on Nausea and Vomiting During Pregnancy. The purpose of this Clinical Study is: to examine the Effects of Different Cannabidiol Doses on Reducing the Frequency and Severity of Nausea in Otherwise Healthy Pregnant Women with Excessive First Trimester Emesis and the Diagnosis of Hyperemesis Gravidarum. Hyperemesis Gravidarum is also known as: Morning Sickness. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol. On December 16, 2021 the IRB acknowledged receipt of the Company’s above-referenced Study Protocol.